CLINICAL TRIAL
Accepted on 31 Jul 2025
Efficacy and Safety of Anlotinib Combined with ¹²⁵I Seed Implantation for Iodine-Refractory Thyroid Cancer
doi 10.3389/fendo.2025.1587412
1,767
Total downloads
10k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
CLINICAL TRIAL
Accepted on 31 Jul 2025
ORIGINAL RESEARCH
Accepted on 30 Jul 2025
ORIGINAL RESEARCH
Accepted on 29 Jul 2025
ORIGINAL RESEARCH
Published on 17 Jun 2025
ORIGINAL RESEARCH
Published on 17 Jun 2025
ORIGINAL RESEARCH
Published on 04 Jun 2025
ORIGINAL RESEARCH
Published on 21 May 2025
ORIGINAL RESEARCH
Published on 25 Apr 2025
ORIGINAL RESEARCH
Published on 24 Mar 2025
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.